The article states absolutely nothing new and basically briefly restates the company's history, quotes the analyst from Nomura, and states that many big events are coming up. It ends up by saying that it's a speculative buy. Someone posted the article on yahoo.
Really it was just a watered down version of what was stated in the BioShares top 10 recommendation list for 2011. The only difference was it didn't appear to have any info or updates direct from management. I speculate it's only had an effect because the readership is more broad.
afr article re cuv, page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.68 |
Change
-0.240(1.61%) |
Mkt cap ! $735.1M | |||
| Open | High | Low | Value | Volume |
| $14.75 | $14.92 | $14.65 | $503.5K | 34.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 448 | $14.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.74 | 149 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |